Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)

Dutch Pancreatic Cancer Group

doi:10.1186/s12885-023-10521-1

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)

Dutch Pancreatic Cancer Group

Vrije Universiteit Amsterdam
University of Amsterdam
Amsterdam UMC
Erasmus University Rotterdam
Utrecht University
Erasmus MC Cancer Institute
Vrije Universiteit (VU) Amsterdam and VU Medical Center

Research output: Contribution to journal › Comment/Letter to the editor › Academic

20 Downloads (Pure)

Abstract

Following publication of the original article [1], the authors reported an error in the author group. The text ?for the Dutch Pancreatic Cancer Group? was missing from the list of authors. This has been updated in the author group above and the original article [1] has been updated.

Original language	English
Article number	70
Journal	BMC cancer
Volume	23
Issue number	1
DOIs	https://doi.org/10.1186/s12885-023-10521-1
Publication status	Published - 1 Dec 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1186/s12885-023-10521-1

Correction.pdfFinal published version, 651 KBLicence: CC BY

Fingerprint

Dive into the research topics of 'Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)'. Together they form a unique fingerprint.

Cite this

Dutch Pancreatic Cancer Group (2023). Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4). BMC cancer, 23(1), Article 70. https://doi.org/10.1186/s12885-023-10521-1

Dutch Pancreatic Cancer Group. / Correction : Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4). In: BMC cancer. 2023 ; Vol. 23, No. 1.

@article{81cae8e6251744969219f8eed2f3e00d,

title = "Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)",

abstract = "Following publication of the original article [1], the authors reported an error in the author group. The text ?for the Dutch Pancreatic Cancer Group? was missing from the list of authors. This has been updated in the author group above and the original article [1] has been updated.",

author = "D. Doppenberg and Besselink, \{M. G.\} and \{van Eijck\}, \{C. H. J.\} and Intven, \{M. P. W.\} and \{Groot Koerkamp\}, B. and G. Kazemier and \{van Laarhoven\}, \{H. W. M.\} and M. Meijerink and Molenaar, \{I. Q.\} and \{Dutch Pancreatic Cancer Group\} and Nuyttens, \{J. J. M. E.\} and \{van Os\}, R. and \{van Santvoort\}, \{H. C.\} and \{van Tienhoven\}, G. and Verkooijen, \{H. M.\} and E. Versteijne and Wilmink, \{J. W.\} and Lagerwaard, \{F. J.\} and Bruynzeel, \{A. M. E.\}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2023.",

year = "2023",

month = dec,

day = "1",

doi = "10.1186/s12885-023-10521-1",

language = "English",

volume = "23",

journal = "BMC cancer",

issn = "1471-2407",

publisher = "BioMed Central Ltd.",

number = "1",

}

Dutch Pancreatic Cancer Group 2023, 'Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)', BMC cancer, vol. 23, no. 1, 70. https://doi.org/10.1186/s12885-023-10521-1

Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4). / Dutch Pancreatic Cancer Group.
In: BMC cancer, Vol. 23, No. 1, 70, 01.12.2023.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Correction

T2 - Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4)

AU - Doppenberg, D.

AU - Besselink, M. G.

AU - van Eijck, C. H. J.

AU - Intven, M. P. W.

AU - Groot Koerkamp, B.

AU - Kazemier, G.

AU - van Laarhoven, H. W. M.

AU - Meijerink, M.

AU - Molenaar, I. Q.

AU - Dutch Pancreatic Cancer Group

AU - Nuyttens, J. J. M. E.

AU - van Os, R.

AU - van Santvoort, H. C.

AU - van Tienhoven, G.

AU - Verkooijen, H. M.

AU - Versteijne, E.

AU - Wilmink, J. W.

AU - Lagerwaard, F. J.

AU - Bruynzeel, A. M. E.

PY - 2023/12/1

Y1 - 2023/12/1

N2 - Following publication of the original article [1], the authors reported an error in the author group. The text ?for the Dutch Pancreatic Cancer Group? was missing from the list of authors. This has been updated in the author group above and the original article [1] has been updated.

AB - Following publication of the original article [1], the authors reported an error in the author group. The text ?for the Dutch Pancreatic Cancer Group? was missing from the list of authors. This has been updated in the author group above and the original article [1] has been updated.

UR - https://www.scopus.com/pages/publications/85146816113

U2 - 10.1186/s12885-023-10521-1

DO - 10.1186/s12885-023-10521-1

M3 - Comment/Letter to the editor

C2 - 36670370

SN - 1471-2407

VL - 23

JO - BMC cancer

JF - BMC cancer

IS - 1

M1 - 70

ER -

Dutch Pancreatic Cancer Group. Correction: Stereotactic ablative radiotherapy or best supportive care in patients with localized pancreatic cancer not receiving chemotherapy and surgery (PANCOSAR): a nationwide multicenter randomized controlled trial according to a TwiCs design (BMC Cancer, (2022), 22, 1, (1363), 10.1186/s12885-022-10419-4). BMC cancer. 2023 Dec 1;23(1):70. doi: 10.1186/s12885-023-10521-1

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this